What is the recommended practice for testing Care Everywhere integration before going live?

• A. Test by running automated scripts without data validation.
• B. Use a test environment, simulate real exchanges, validate consent, verify patient matching, validate CCDA structure, and review audit trails.
• C. Skip testing and deploy after a quick pilot.
• D. Test only in production.

Answer: (B)

When testing Care Everywhere before going live, the goal is to validate the entire out-of-production workflow in a safe, realistic way. Using a dedicated test environment lets you simulate real exchanges without exposing patient data, so you can run end-to-end scenarios that mirror how the integration will function after launch. You’ll verify that consent is properly handled and enforced across systems, ensure that patient matching correctly links records from different sources to the same person, and check that CCDA documents conform to the standard, include the necessary clinical sections, and render correctly for the receiving EHR. Reviewing audit trails is essential to confirm who accessed data, what was exchanged, and when, which supports security, compliance, and troubleshooting.

This approach is superior because it covers the full spectrum of readiness: consent workflows, patient identity resolution, data structure validity, and traceability before any real patients are involved. Alternatives that skip data validation, skip thorough testing, rely only on a quick pilot, or test exclusively in production miss critical checks and introduce risk of data exposure, interoperability gaps, or system outages when you go live.